PROMO!First order? Get 10% OFF with this code: 1storder
🇪🇺 € EUR
0.00€ Cart
PROMO!First order? Get 10% OFF with this code: 1storder
<ú<ø € EUR0.00€ Cart
Home / DSIP / DSIP Pre-Mixed Peptide
Buy DSIP Pre-Mixed Peptide from Peptide Works

DSIP Pre-Mixed Peptide

DSIP (Delta Sleep-Inducing Peptide) is a neuropeptide studied for its potential to regulate sleep, reduce stress hormones, enhance cognitive function and modulate hormonal activity.

DSIP Pre-mixed Pen kit contains: 1 x DSIP 5mg Cartridge (premixed with Bacteriostatic Water), 1 x Cartridge Pen with 3 Pen Needle Tips, plus a Pen Carry Case.

Single DSIP Pre-mixed Cartridges: DSIP 5mg 1, 2 or 3 x Cartridge (premixed with Bacteriostatic Water) plus 3 Pen Needle Tips. (Single mixed cartridges do not contain the pen or case).

Price: Price range: 41.49€ through 112.02€

SKU N/A
Categories ,
 Guaranteed High Purity +99% Pure
 New Customer Discount (code: 1storder) Get 10% off your first order
Description

Buy DSIP Pre-Mixed Peptide in Europe

 

Order DSIP Pre-Mixed Peptide for streamlined research in Europe.
This ready-to-use DSIP solution arrives pre-dosed, lab-tested, and sealed for stability. No reconstitution needed.

We ship to UK and Germany in 48H from EU stock with tracking.
Researchers in France and Spain choose DSIP pre-mixed for accuracy and convenience.
You can also purchase DSIP peptide to Italy with secure, fast EU fulfillment.

Want to buy DSIP or shop pre-mixed peptide online? Fresh batches are available now for Europe-wide delivery.
For laboratory use only. Not for human consumption.

 

DSIP Pre-Mixed Peptide

Overview of DSIP Pre-Mixed Peptide

DSIP Pre-Mixed Peptide is a prepared research formulation containing Delta Sleep-Inducing Peptide (DSIP), a naturally occurring nonapeptide that has been investigated primarily in relation to sleep regulation, neurophysiology, circadian activity, and neuroendocrine processes.

DSIP was originally identified through research into sleep-related biological activity. The National Library of Medicine describes DSIP as a nonapeptide found in neurons, peripheral organs, and plasma that has been studied for effects involving sleep, electrophysiological activity, neurotransmitter levels, circadian patterns, hormonal activity, and related physiological processes. (MeSH Browser)

A pre-mixed formulation differs from a lyophilized peptide because it is supplied as a prepared solution according to the manufacturer’s specifications. Concentration, excipients, container type, stability, and storage requirements can vary between manufacturers.

What Is DSIP Pre-Mixed Peptide?

DSIP Pre-Mixed Peptide is a manufacturer-prepared formulation containing a specified concentration of synthetic DSIP. It is generally marketed as a research product rather than an established pharmaceutical treatment.

Potential product characteristics include:

  • Prepared liquid peptide formulation
  • Contains Delta Sleep-Inducing Peptide
  • Manufacturer-specified concentration
  • Batch or lot identification
  • Quality-control documentation where available
  • Manufacturer-specific storage instructions
  • Research-oriented packaging

The actual composition should always be verified using the product label and, where available, a certificate of analysis.

Features of DSIP Pre-Mixed Peptide

Potential features include:

  • Ready-prepared formulation
  • No powder reconstitution required
  • Clearly stated peptide concentration
  • Secure packaging
  • Batch traceability
  • Manufacturer-specific handling information
  • Research-focused presentation

A pre-mixed presentation does not by itself establish clinical effectiveness, pharmaceutical approval, or long-term safety.

Research Background of DSIP Pre-Mixed Peptide

DSIP was first characterized as a nonapeptide associated with slow-wave or delta-wave sleep research. Experimental work identified its amino-acid sequence as Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu. (PubMed)

Human research conducted several decades ago examined DSIP in people with sleep disturbances. One 1981 clinical study involving six chronic insomniacs reported changes in sleep duration and sleep quality following intravenous administration. (PubMed)

However, subsequent research produced more qualified findings. A 1987 double-blind crossover study in chronic insomniacs reported some changes in sleep parameters but concluded that the overall clinical significance of the sleep improvement was limited. (PubMed)

These studies are relatively old and involved small numbers of participants. They do not provide sufficient modern evidence to establish DSIP as an approved treatment for insomnia or other sleep disorders.

DSIP Pre-Mixed Peptide and Sleep Research

The primary scientific interest surrounding DSIP involves its possible relationship with sleep regulation.

Research has examined:

  • Sleep architecture
  • Slow-wave or delta sleep
  • Sleep continuity
  • Circadian regulation
  • Neuroendocrine signaling
  • Neurotransmitter activity
  • Electrophysiological changes
  • Sleep-wake behavior

Early human studies reported potentially favorable changes in sleep, but the evidence has not developed into a sufficiently robust modern clinical evidence base. (PubMed)

Therefore, it is more accurate to describe DSIP as an investigational sleep-related peptide rather than a proven treatment for insomnia.

Potential Research Applications of DSIP Pre-Mixed Peptide

Scientific investigations involving DSIP have explored:

  • Sleep physiology
  • Sleep-wake regulation
  • Circadian biology
  • Neurophysiology
  • Neuroendocrine research
  • Electrophysiological activity
  • Neurotransmitter research
  • Laboratory peptide research

These areas represent research interests and should not be interpreted as established therapeutic indications.

Safety Information for DSIP Pre-Mixed Peptide

The long-term safety profile of DSIP has not been established through large, contemporary clinical trials.

Historical human studies reported relatively few adverse effects under their specific experimental conditions, but those findings should not be generalized to modern commercial formulations, different routes of administration, different concentrations, or repeated long-term exposure. (PubMed)

Important considerations include:

  • Research formulations should not automatically be treated as medicines.
  • Product purity and concentration can vary between manufacturers.
  • The route of administration can influence safety and pharmacokinetics.
  • Long-term human safety remains insufficiently characterized.
  • Commercial claims should be distinguished from peer-reviewed evidence.

Storage Guidelines for DSIP Pre-Mixed Peptide

Storage requirements depend on the particular formulation and manufacturer.

General considerations include:

  • Follow the manufacturer’s stated storage conditions.
  • Keep the container in its original packaging.
  • Protect the product from excessive heat and direct light.
  • Follow any refrigeration requirements specified on the label.
  • Avoid using products with damaged or compromised packaging.
  • Observe the manufacturer’s stated shelf life.

Manufacturer-specific stability information should take precedence over generic peptide-storage recommendations.

Disposal of DSIP Pre-Mixed Peptide

Unused or expired material should be disposed of according to applicable laboratory, pharmaceutical, and local waste-disposal requirements.

Do not reuse damaged or compromised containers.

Frequently Asked Questions About DSIP Pre-Mixed Peptide

What is DSIP Pre-Mixed Peptide?

DSIP Pre-Mixed Peptide is a prepared research formulation containing Delta Sleep-Inducing Peptide, a nonapeptide studied primarily in relation to sleep regulation and neurophysiology. (MeSH Browser)

What is DSIP?

DSIP stands for Delta Sleep-Inducing Peptide. It is a nonapeptide that has been investigated for possible effects on sleep, circadian patterns, neurotransmitter activity, electrophysiology, and neuroendocrine processes. (MeSH Browser)

What is DSIP Pre-Mixed Peptide used for?

It is associated with laboratory research involving sleep physiology, sleep-wake regulation, circadian biology, and neurophysiological processes. It should not be presented as an established treatment for insomnia or other medical conditions.

Has DSIP been studied in humans?

Yes. Older clinical studies investigated synthetic DSIP in people with sleep disturbances and reported changes in several sleep parameters. However, these studies were small and produced mixed conclusions regarding clinical significance. (PubMed)

Is DSIP approved as a sleep medicine?

DSIP should not be described as an approved sleep medicine. The available evidence is limited and predominantly based on older experimental and small clinical studies.

Is the pre-mixed form the same as lyophilized DSIP?

Both formulations may contain the same peptide, but their physical presentation is different. A pre-mixed product is supplied as a prepared solution, whereas a lyophilized product is supplied in a dried form. Concentration, excipients, stability, and storage requirements may therefore differ.

 

ALL CONTENT AND PRODUCT INFORMATION AVAILABLE ON THIS WEBSITE IS FOR EDUCATIONAL PURPOSES ONLY.

DISCLAIMER: Products are supplied for research purposes only and are not intended to diagnose, treat, cure, or prevent any disease.

You may also like&

View All Products